Valuation: biote Corp.

Market Cap 65.82M 57.56M 52.83M 49.32M 93.45M 6.27B 94.84M 635M 247M 3.08B 247M 242M 10.62B P/E 2026 *
10.2x
P/E 2027 * 7.4x
Enterprise Value 152M 133M 122M 114M 215M 14.44B 219M 1.46B 569M 7.09B 569M 557M 24.47B EV / Sales 2026 *
0.79x
EV / Sales 2027 * 0.68x
Free-Float
85.15%
Yield 2026 *
-
Yield 2027 * -
1 day+9.05%
1 week+21.23%
Current month+14.81%
1 month+2.84%
3 months+36.48%
6 months-12.15%
Current year-16.54%
1 week 1.63
Extreme 1.63
2.2
1 month 1.63
Extreme 1.63
2.5
Current year 1.27
Extreme 1.27
2.68
1 year 1.27
Extreme 1.27
4.75
3 years 1.27
Extreme 1.27
8.44
5 years 1.27
Extreme 1.27
10.52
10 years 1.27
Extreme 1.27
10.52
Manager TitleAgeSince
Chief Executive Officer 49 2026-06-11
Chief Tech/Sci/R&D Officer 69 2024-02-29
General Counsel 46 2021-05-31
Director TitleAgeSince
Director/Board Member 68 2022-04-30
Chairman 61 2022-04-30
Director/Board Member 67 2022-11-02
Date Insider Type Main position Quantity % Market Cap.
06-11Free

Chief Executive Officer

206,746 0.6816%
06-07Free

Chief Executive Officer

130,000 0.4286%
06-07Free

Chairman

114,157 0.3764%
Change 5-day change 1-year change 3-year change Capi.($)
+9.05%+21.23%-48.58%-67.95% 65.82M
-0.91%+3.10%-20.20%+23.09% 149M
-8.18%-10.62%-29.86%-89.28% 113M
0.00%+26.32%+14.29%+4.35% 59.16M
Average -0.01%+9.08%-21.09%-32.45% 96.65M
Weighted average by Cap. -1.20%+5.93%-22.58%-28.14%

Financials

2026 *2027 *
Net sales 191M 167M 153M 143M 271M 18.16B 275M 1.84B 715M 8.92B 716M 701M 30.78B 204M 178M 163M 153M 289M 19.38B 293M 1.96B 763M 9.52B 764M 748M 32.84B
Net income 7.74M 6.77M 6.21M 5.8M 10.99M 737M 11.15M 74.62M 29.01M 362M 29.05M 28.42M 1.25B 10.67M 9.33M 8.57M 8M 15.15M 1.02B 15.38M 103M 40M 499M 40.07M 39.19M 1.72B
Net Debt 85.86M 75.09M 68.91M 64.33M 122M 8.17B 124M 828M 322M 4.01B 322M 315M 13.85B 71.8M 62.8M 57.64M 53.8M 102M 6.84B 103M 692M 269M 3.36B 270M 264M 11.58B
Logo biote Corp.
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Employees
223
Date Price Change Volume
26-07-02 US$2.170 +9.05% 265,157
26-07-01 US$1.990 +5.29% 246,128
26-06-30 US$1.890 +13.17% 537,839
26-06-29 US$1.670 -6.70% 715,151
26-06-26 US$1.790 -8.67% 3,254,520
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.170USD
Average target price
2.986USD
Spread / Average Target
+37.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BTMD Stock